Loading organizations...
Loading organizations...
Biotechnology company developing treatments for rare genetic diseases.
ORIG3N has raised $15.6M across 2 funding rounds.
ORIG3N has raised $15.6M in total across 2 funding rounds.
ORIG3N has raised $15.6M in total across 2 funding rounds.
ORIG3N's investors include Clay B. Thorp, Justin Xiang, DEFTA Partners, Douglas W. Jamison, KTB-KORUS Fund, Labcorp, Mountain Group Partners, Harris & Harris Group, KTB Network.
ORIG3N has raised $15.6M across 2 funding rounds. Most recently, it raised $12.5M Series A in December 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 16, 2015 | $12.5M Series A | Clay B. Thorp, Justin Xiang | DEFTA Partners, Douglas W. Jamison, KTB-KORUS Fund, Labcorp, Mountain Group Partners |
| Feb 6, 2015 | $3.1M Other Equity | Harris & Harris Group, Clay B. Thorp, KTB Network, Mountain Group Partners |